Amag Pharmaceuticals, Inc.

Formerly NASDAQ: AMAG
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 5 pages Third Supplemental Indenture
12/34/56
EX-4.2
from 8-K 5 pages Third Supplemental Indenture
12/34/56
EX-4.1
from 8-K 5 pages Second Supplemental Indenture
12/34/56
EX-4.1
from 8-K 5 pages Second Supplemental Indenture
12/34/56
EX-4.8
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.6
from S-3ASR 48 pages Amag Pharmaceuticals, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [·], 201[·] Subordinated Debt Securities
12/34/56
EX-4.2
from 8-K 93 pages AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association, as Trustee First Supplemental Indenture Dated as of May 10, 2017 to Indenture Dated as of May 10, 2017 3.25% Convertible Senior Notes Due 2022
12/34/56
EX-4.1
from 8-K 44 pages AMAG Pharmaceuticals, Inc. Issuer and Wilmington Trust, National Association Trustee Indenture Dated as of May 10, 2017
12/34/56
EX-4.3
from 8-K 6 pages Form of Right Certificate
12/34/56
EX-4.2
from 8-K 43 pages Amag Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC as Rights Agent Rights Agreement Dated as of April 7, 2017 Rights Agreement
12/34/56
EX-4.1
from 8-K 146 pages AMAG Pharmaceuticals, Inc. 7.875% Senior Notes Due 2023 Indenture Dated as of August 17, 2015 Wilmington Trust, National Association, Trustee
12/34/56
EX-4.9
from S-3ASR 53 pages AMAG Pharmaceuticals, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [·], 201[·]
12/34/56
EX-4.9
from S-3ASR 15 pages Registration Rights and Lock-Up Agreement
12/34/56
EX-4.1
from 8-K 15 pages Nol Amendment to Rights Agreement
12/34/56
EX-4.4
from 8-K 3 pages Amendment to Rights Agreement
12/34/56
EX-4.2
from 8-K 88 pages Amag Pharmaceuticals, Inc. and Wilmington Trust, National Association, as Trustee First Supplemental Indenture Dated as of February 14, 2014 to Indenture for Senior Debt Securities Dated as of February 14, 2014 2.50% Convertible Senior Notes Due 2019
12/34/56
EX-4.1
from 8-K 40 pages Amag Pharmaceuticals, Inc. Issuer and Wilmington Trust, National Association, Trustee Indenture Dated as of February 14, 2014 Senior Debt Securities
12/34/56
EX-4.13
from S-3 13 pages Amag Pharmaceuticals, Inc. and [·], as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of [·] Amag Pharmaceuticals, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.12
from S-3 13 pages Amag Pharmaceuticals, Inc. and [·], as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of [·] Amag Pharmaceuticals, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.11
from S-3 15 pages Amag Pharmaceuticals, Inc. and [·], as Warrant Agent Form of Common Stock Warrant Agreement Dated as of [·] Amag Pharmaceuticals, Inc. Form of Common Stock Warrant Agreement
12/34/56